News

Illustration of the lymphatic system. Credit: Shutterstock

2022 Jan 19

Research Illuminates How Melanoma Readies Lymph Nodes for Tumor Spread

Illustration of the lymphatic system. Credit: Shutterstock Melanoma cells release small extracellular packages containing the protein nerve growth factor receptor, which primes nearby lymph nodes for tumor metastases,... Read more

2022 Jan 04

Portable Prostate Cancer Test May Help Reach Underserved Men

A highly portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer and particularly those with limited access to health care, such as African... Read more

2022 Jan 03

Dr. Ari Melnick's Study: Lymphoma Cell Metabolism May Provide New Cancer Target

Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study... Read more

2021 Dec 15

Reducing Copper in the Body Alters Cancer Metabolism to Reduce Risk of Aggressive Breast Cancer

Depleting copper levels may reduce the production of energy that cancer cells need to travel and establish themselves in other parts of the body by a process referred to as metastasis, according to a new study by... Read more

Silvia Formenti, M.D., is pioneering the use of radiation for immunotherapy in cancer

2021 Dec 09

Led by Dr. Silvia C. Formenti: Department of Defense Awards Weill Cornell Medicine New Grant for Breast Cancer Research

Weill Cornell Medicine has been awarded a nearly $6.5 million, four-year grant from the Department of Defense as part of a multi-institutional Transformative Breast Cancer Consortium. The award will fund research on the... Read more

2021 Dec 09

Dr. Olivier Elemento's study: Tumors differ depending on age of cancer patients

Investigators at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types. Their research, published Dec. 7... Read more

2021 Nov 23

Led by Dr. Jaffrey: National Human Genome Research Institute Funds $12.2 Million Center at Weill Cornell Medicine to Study RNA Modifications

The National Human Genome Research Institute has funded a multi-institutional Center of Excellence in Genome Sciences (CEGS) , based at Weill Cornell Medicine, to develop new tools to study the major product of the human... Read more

2021 Nov 05

Dr. Leandro Cerchietti's Study: Arginine, an Inexpensive Oral Drug, Could Enhance Radiation Therapy for Cancer

Treatment with arginine, one of the amino-acid building blocks of proteins, enhanced the effectiveness of radiation therapy in cancer patients with brain metastases, in a proof-of-concept, randomized clinical trial from... Read more

2021 Oct 14

Dr. Leandro Cerchietti's Study Uncovers a Key Vulnerability of Aggressive Lymphomas

Lymphomas can turbo-charge their ability to proliferate by crowding growth-supporting enzymes into highly concentrated compartments within tumor cells, according to a study led by researchers at Weill Cornell Medicine. The... Read more

2021 Sep 30

Dr. Dan Landau's Study: Powerful Technique Details Brain Tumors’ Formidable Resiliency

A team led by researchers at Weill Cornell Medicine, the New York Genome Center , Harvard Medical School , Massachusetts General Hospital and the Broad Institute of MIT and Harvard has profiled in unprecedented detail... Read more

Illustration of B cells, antibodies and red blood cells. Credit: Shutterstock

2021 Sep 23

Antibody-Producing B Cells May be "Predestined" for their Fates

Illustration of B cells, antibodies and red blood cells. Credit: Shutterstock The master regulator behind the development of antibody-producing cells has been identified in a study by investigators at Weill Cornell Medicine... Read more

Multiplex immunofluorescence image of immune cell-infiltrated human colorectal cancer. Tumor cells are labeled with PKCi (magenta), immune cells are labeled with CD8 (red) and nuclei in white. Image courtesy of Dr. Jorge Moscat.

2021 Sep 23

Enhancing Immune System Discovery of Tumors Might Combat Colorectal Cancer

Multiplex immunofluorescence image of immune cell-infiltrated human colorectal cancer. Tumor cells are labeled with PKCi (magenta), immune cells are labeled with CD8 (red) and nuclei in white. Image courtesy of Dr. Jorge... Read more

Immunofluorescent images of lungs treated with radiation (left) or no radiation (right). Club cells secrete more anti-immunosuppressive factors when treated with radiation, as seen by the increase in the secretory marker CC10 (yellow).

2021 Sep 20

Scientists Find a New Way to Reverse Immune Suppression in Tumors

Primary Image Description & Credit: Immunofluorescent images of lungs treated with radiation (left) or no radiation (right). Club cells secrete more anti-immunosuppressive factors when treated with radiation, as seen by... Read more

2021 Sep 13

Dr. Ashley Laughney's Study: Uveal Melanoma Discovery Points to New Treatment Possibilities

A team co-led by scientists at Weill Cornell Medicine has revealed in detail how the most common primary eye cancer in adults, uveal melanoma (UM), can progress from a slow-growing, “indolent” state to a lethal metastasizing... Read more

Personalized Care: Dr. Gail Roboz (above right), examines patient Cheryl Bonder this spring as part of her ongoing treatment

2021 Sep 07

It’s an Absolute Miracle: Battling a Deadly Blood Cancer, a New Jersey Woman Gets a Second Chance — Thanks to Precision Medicine

Cheryl Bonder had been living with a vaguely defined blood malignancy for years when her prognosis rapidly took a turn for the worse: her condition was progressing toward acute myelogenous leukemia (AML), an aggressive... Read more

Image courtesy of Samuel Taylor and Dr. Marcus Goncalves

2021 Aug 18

Research Illuminates How Melanoma Readies Lymph Nodes for Tumor Spread

Portable Prostate Cancer Test May Help Reach Underserved Men

Dr. Ari Melnick's Study: Lymphoma Cell Metabolism May Provide New Cancer Target

Reducing Copper in the Body Alters Cancer Metabolism to Reduce Risk of Aggressive Breast Cancer

Led by Dr. Silvia C. Formenti: Department of Defense Awards Weill Cornell Medicine New Grant for Breast Cancer Research

Dr. Olivier Elemento's study: Tumors differ depending on age of cancer patients

Led by Dr. Jaffrey: National Human Genome Research Institute Funds $12.2 Million Center at Weill Cornell Medicine to Study RNA Modifications

Dr. Leandro Cerchietti's Study: Arginine, an Inexpensive Oral Drug, Could Enhance Radiation Therapy for Cancer

Dr. Leandro Cerchietti's Study Uncovers a Key Vulnerability of Aggressive Lymphomas

Dr. Dan Landau's Study: Powerful Technique Details Brain Tumors’ Formidable Resiliency

Antibody-Producing B Cells May be "Predestined" for their Fates

Enhancing Immune System Discovery of Tumors Might Combat Colorectal Cancer

Scientists Find a New Way to Reverse Immune Suppression in Tumors

Dr. Ashley Laughney's Study: Uveal Melanoma Discovery Points to New Treatment Possibilities

It’s an Absolute Miracle: Battling a Deadly Blood Cancer, a New Jersey Woman Gets a Second Chance — Thanks to Precision Medicine

Goncalves Lab's Research Uncovers How Fructose in the Diet Contributes to Obesity

Key Immune Cells Maintain Healthy Gut Bacteria to Protect Against Colorectal Cancer

New Treatment Option for Advanced Urothelial Cancer Patients Shows Promise in a Phase 2 Clinical Trial

Scientists Discover a Powerful Natural Immune-Regulating Molecule

Cancer Vaccine Improves Outcomes in Lynch Syndrome Model

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters